Kindred Healthcare Reports First Quarter 2016 Results

Go back to Kindred Healthcare Reports First Quarter 2016 Results

Mizuho Securities Remains Sidelined on Kindred Healthcare (KND) - PT to $13.50

May 5, 2016 7:17 AM EDT

Mizuho Securities reiterated a Neutral rating on Kindred Healthcare (NYSE: KND), and raised the price target to $13.50 (from $9.00), following the company's 1Q earnings report.

Analyst Sheryl Skolnick commented, "KND's 1Q Core EBITDAR of $247mm beat consensus by $3mm on the... More

Kindred Healthcare (KND) Tops Q1 EPS by 13c

May 4, 2016 4:58 PM EDT

Kindred Healthcare (NYSE: KND) reported Q1 EPS of $0.35, $0.13 better than the analyst estimate of $0.22. Revenue for the quarter came in at $1.84 billion versus the consensus estimate of $1.84 billion.

Kindred Healthcare reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Kindred Healthcare (KND) click here.

... More